Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Reduction Of TGFB Signaling In Myeloid Cells In The Treatment Of Cancer

  • Read more about Reduction Of TGFB Signaling In Myeloid Cells In The Treatment Of Cancer
US Patent 9,115,371
Filed on 2012-08-20

The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer

  • Read more about The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer
Patent Cooperation Treaty
PCT/US12/29636
Filed on 2012-03-19

HIV Integrase Inhibitory Oxoisoindoline Sulfonamides

  • Read more about HIV Integrase Inhibitory Oxoisoindoline Sulfonamides
Patent Cooperation Treaty
PCT/US2012/048169
Filed on 2012-07-25

Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases

  • Read more about Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases
US Patent 8,633,177
Filed on 2012-09-04

Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases

  • Read more about Nitroxyl (HNO) Releasing Compounds And Uses Thereof In Treating Diseases
European Patent
11711417.3
Filed on 2011-03-18

Mutated Pseudomonas Exotoxins with Reduced Immunogenicity

  • Read more about Mutated Pseudomonas Exotoxins with Reduced Immunogenicity
Australia
2012216642
Filed on 2012-08-28

Radiolabeling Of Affibody Molecules

  • Read more about Radiolabeling Of Affibody Molecules
US Application 13/608,054
Filed on 2012-09-10

Combination Immunotherapy Compositions And Methods

  • Read more about Combination Immunotherapy Compositions And Methods
Israel
201039
Filed on 2010-04-16

COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS

  • Read more about COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS
Hong Kong
12105197.6
Filed on 2010-04-16

Dual Specific Immunotoxin for Brain Tumor Therapy

  • Read more about Dual Specific Immunotoxin for Brain Tumor Therapy
US Application 13/482,406
Filed on 2012-05-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 733
  • Page 734
  • Page 735
  • Page 736
  • Page 737
  • Page 738
  • Page 739
  • Page 740
  • Page 741
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health